Silgan Holdings Inc (SLGN) stock
Close on Nov 13, 2026Market cap $4.32BP/E 16.5Yield 1.96%
Earnings
Silgan's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Silgan's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 3, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 29, 2026after the close | $2.04B | +1.5% | $0.99 | $1.31 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 29, 2026after the close | $1.64B | +6.5% | $0.72 | $0.98 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 29, 2026after the close | $1.56B | +6.1% | $0.60 | $0.78 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 4, 2026after the close | $1.47B | +5.0% | $0.17 | $0.67 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 29, 2025after the close | $2.01B | +14.9% | $1.06 | $1.22 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 30, 2025after the close | $1.54B | +11.6% | $0.83 | $1.01 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 30, 2025after the close | $1.47B | +11.4% | $0.63 | $0.82 | Release |
| Q4 FY2024ended Dec 31, 2024 | Jan 29, 2025after the close | $1.40B | +7.7% | $0.42 | $0.85 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 30, 2024after the close | $1.75B | -2.8% | $0.93 | $1.21 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 31, 2024after the close | $1.38B | -3.5% | $0.71 | $0.88 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 2, 2024after the close | $1.32B | -7.0% | $0.52 | $0.69 | Release |
| Q4 FY2023ended Dec 31, 2023 | Jan 31, 2024after the close | $1.30B | -11.0% | $0.60 | $0.63 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 25, 2023after the close | $1.80B | -8.6% | $1.02 | $1.16 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 26, 2023after the close | $1.43B | -7.1% | $0.71 | $0.83 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 26, 2023after the close | $1.42B | -1.4% | $0.65 | $0.78 | Release |
| Q4 FY2022ended Dec 31, 2022 | Jan 25, 2023after the close | $1.46B | +1.4% | $0.22 | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 26, 2022after the close | $1.97B | +19.4% | $1.25 | $1.27 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 27, 2022after the close | $1.54B | – | $0.83 | $1.08 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 27, 2022after the close | $1.44B | – | $0.76 | $0.78 | Release |
| Q4 FY2021ended Dec 31, 2021 | Jan 26, 2022after the close | $1.44B | – | $0.76 | $0.79 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 27, 2021after the close | $1.65B | – | $0.96 | $1.02 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 28, 2021after the close | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 28, 2021after the close | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Jan 27, 2021after the close | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 21, 2020after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Silgan's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| adjusted net income per diluted sharenon-GAAP | Q4 FY2026 | $0.76 – $0.86 | – | New | Oct 29, 2026 |
| U.S. GAAP diluted EPSGAAP | FY2026 | $3.00 – $3.20 | $3.20 – $3.40 | Lowered | Jul 29, 2026 |
| adjusted net income per diluted sharenon-GAAP | FY2026 | $3.83 – $3.93 | – | New | Oct 29, 2026 |
| adjusted net income per diluted sharenon-GAAP | FY2026 | $3.73 – $3.93 | $3.73 – $3.93 | Reaffirmed | Jul 29, 2026 |
| free cash flownon-GAAP | FY2026 | $450.00M | – | New | Oct 29, 2026 |
| free cash flownon-GAAP | FY2026 | $450.00M | $450.00M | Reaffirmed | Jul 29, 2026 |
| free cash flow | FY2026 | $450.00M | – | New | Apr 29, 2026 |
| Capital expendituresGAAP | FY2026 | $310.00M | – | New | Oct 29, 2026 |
| Capital expenditures | FY2026 | $310.00M | $310.00M | Reaffirmed | Jul 29, 2026 |
| effective tax rate | FY2026 | 25% – 26% | – | New | Feb 4, 2026 |
| interest and other debt expense | FY2026 | $205.00M | – | New | Feb 4, 2026 |
Guidance vs results
The last range Silgan gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | adjusted net income per diluted share | $1.21 – $1.31 | $1.31 | Within range |
| Q3 FY2026 | EPS (GAAP) | $1.05 – $1.15 | $0.99 | Below range |
| Q2 FY2026 | adjusted net income per diluted share | $0.92 – $1.02 | $0.98 | Within range |
| Q2 FY2026 | EPS (GAAP) | $0.76 – $0.86 | $0.72 | Below range |
| Q1 FY2026 | adjusted net income per diluted share | $0.70 – $0.80 | $0.78 | Within range |
| Q1 FY2026 | EPS (GAAP) | $0.56 – $0.66 | $0.60 | Within range |
| FY2025 | adjusted net income per diluted share | $3.66 – $3.76 | $3.72Σ4Q | Within range |
| FY2025 | EPS (GAAP) | $2.98 – $3.08 | $2.69Σ4Q | Below range |
| Q4 FY2025 | adjusted net income per diluted share | $0.62 – $0.72 | $0.67 | Within range |
| Q4 FY2025 | EPS (GAAP) | $0.47 – $0.57 | $0.17 | Below range |
| Q3 FY2025 | adjusted net income per diluted share | $1.18 – $1.28 | $1.22 | Within range |
| Q3 FY2025 | EPS (GAAP) | $1.04 – $1.14 | $1.06 | Within range |
| Q2 FY2025 | adjusted net income per diluted share | $0.98 – $1.08 | $1.01 | Within range |
| Q2 FY2025 | EPS (GAAP) | $0.85 – $0.95 | $0.83 | Below range |
| Q1 FY2025 | adjusted net income per diluted share | $0.74 – $0.84 | $0.82 | Within range |
| Q4 FY2024 | adjusted net income per diluted share | $0.78 – $0.88 | $0.85 | Within range |
| Q3 FY2024 | adjusted net income per diluted share | $1.20 – $1.30 | $1.21 | Within range |
| Q3 FY2024 | EPS (GAAP) | $1.06 – $1.16 | $0.93 | Below range |
| Q2 FY2024 | adjusted net income per diluted share | $0.82 – $0.92 | $0.88 | Within range |
| Q1 FY2024 | adjusted net income per diluted share | $0.60 – $0.70 | $0.69 | Within range |
| Q4 FY2023 | EPS (GAAP) | $0.43 – $0.53 | $0.60 | Above range |
| Q3 FY2023 | adjusted net income per diluted share | $1.10 – $1.20 | $1.16 | Within range |
| Q1 FY2023 | adjusted net income per diluted share | $0.75 – $0.85 | $0.78 | Within range |
| Q3 FY2022 | adjusted net income per diluted share | $1.15 – $1.30 | $1.27 | Within range |
| Q3 FY2022 | EPS (GAAP) | $1.14 – $1.29 | $1.25 | Within range |
| Q2 FY2022 | adjusted net income per diluted share | $0.90 – $1.00 | $1.08 | Above range |
| Q1 FY2022 | adjusted net income per diluted share | $0.70 – $0.80 | $0.78 | Within range |
| Q4 FY2021 | adjusted net income per diluted share | $0.69 – $0.79 | $0.79 | Within range |
Guidance history
Every forecast Silgan put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 29, 2026 | Capital expenditures | FY2026 | $310.00M | New |
| Oct 29, 2026 | adjusted net income per diluted share | Q4 FY2026 | $0.76 – $0.86 | New |
| Oct 29, 2026 | adjusted net income per diluted share | FY2026 | $3.83 – $3.93 | New |
| Oct 29, 2026 | free cash flow | FY2026 | $450.00M | New |
| Jul 29, 2026 | Capital expenditures | FY2026 | $310.00M | Reaffirmed |
| Jul 29, 2026 | adjusted net income per diluted share | FY2026 | $3.73 – $3.93 | Reaffirmed |
| Jul 29, 2026 | adjusted net income per diluted share | Q3 FY2026 | $1.21 – $1.31 | New |
| Jul 29, 2026 | U.S. GAAP diluted EPS | FY2026 | $3.00 – $3.20 | Lowered |
| Jul 29, 2026 | U.S. GAAP diluted EPS | Q3 FY2026 | $1.05 – $1.15 | New |
| Jul 29, 2026 | free cash flow | FY2026 | $450.00M | Reaffirmed |
| Apr 29, 2026 | Capital expenditures | FY2026 | $310.00M | Reaffirmed |
| Apr 29, 2026 | adjusted net income per diluted share | FY2026 | $3.73 – $3.93 | Raised |
| Apr 29, 2026 | adjusted net income per diluted share | Q2 FY2026 | $0.92 – $1.02 | New |
| Apr 29, 2026 | U.S. GAAP diluted EPS as estimated for 2026 | Q2 FY2026 | $0.76 – $0.86 | New |
| Apr 29, 2026 | free cash flow | FY2026 | $450.00M | New |
| Feb 4, 2026 | Capital expenditures | FY2026 | $310.00M | New |
| Feb 4, 2026 | adjusted net income per diluted share | FY2026 | $3.70 – $3.90 | New |
| Feb 4, 2026 | adjusted net income per diluted share | Q1 FY2026 | $0.70 – $0.80 | New |
| Feb 4, 2026 | U.S. GAAP diluted EPS | FY2026 | $3.20 – $3.40 | New |
| Feb 4, 2026 | U.S. GAAP diluted EPS | Q1 FY2026 | $0.56 – $0.66 | New |
| Feb 4, 2026 | free cash flow | FY2026 | $450.00M | New |
| Feb 4, 2026 | effective tax rate | FY2026 | 25% – 26% | New |
| Feb 4, 2026 | interest and other debt expense | FY2026 | $205.00M | New |
| Oct 29, 2025 | Capital expenditures | FY2025 | $300.00M | New |
| Oct 29, 2025 | adjusted net income per diluted share | FY2025 | $3.66 – $3.76 | New |
| Oct 29, 2025 | adjusted net income per diluted share | Q4 FY2025 | $0.62 – $0.72 | New |
| Oct 29, 2025 | U.S. GAAP diluted EPS | FY2025 | $2.98 – $3.08 | New |
| Oct 29, 2025 | U.S. GAAP diluted EPS | Q4 FY2025 | $0.47 – $0.57 | New |
| Oct 29, 2025 | free cash flow | FY2025 | $430.00M | New |
| Oct 29, 2025 | adjusted tax rate | FY2025 | 24.5% | New |
| Oct 29, 2025 | interest and other debt expense | FY2025 | $190.00M | New |
| Jul 30, 2025 | Capital expenditures | FY2025 | $300.00M | Reaffirmed |
| Jul 30, 2025 | adjusted net income per diluted share | Q3 FY2025 | $1.18 – $1.28 | New |
| Jul 30, 2025 | adjusted net income per diluted share | FY2025 | $3.85 – $4.05 | Lowered |
| Jul 30, 2025 | U.S. GAAP diluted EPS | Q3 FY2025 | $1.04 – $1.14 | New |
| Jul 30, 2025 | free cash flow | FY2025 | $430.00M | Lowered |
| Jul 30, 2025 | effective tax rate | FY2025 | 24% | Reaffirmed |
| Jul 30, 2025 | interest and other debt expense | FY2025 | $185.00M | Reaffirmed |
| Apr 30, 2025 | Capital expenditures | FY2025 | $300.00M | Reaffirmed |
| Apr 30, 2025 | adjusted net income per diluted share | Q2 FY2025 | $0.98 – $1.08 | New |
| Apr 30, 2025 | adjusted net income per diluted share | FY2025 | $4.00 – $4.20 | Reaffirmed |
| Apr 30, 2025 | U.S. GAAP diluted EPS | Q2 FY2025 | $0.85 – $0.95 | New |
| Apr 30, 2025 | U.S. GAAP diluted EPS | FY2025 | $3.42 – $3.62 | New |
| Apr 30, 2025 | free cash flow | FY2025 | $450.00M | New |
| Apr 30, 2025 | effective tax rate | FY2025 | 24% | Reaffirmed |
| Apr 30, 2025 | interest and other debt expense | FY2025 | $185.00M | Reaffirmed |
| Jan 29, 2025 | Capital expenditures | FY2025 | $300.00M | New |
| Jan 29, 2025 | adjusted net income per diluted share | Q1 FY2025 | $0.74 – $0.84 | New |
| Jan 29, 2025 | adjusted net income per diluted share | FY2025 | $4.00 – $4.20 | New |
| Jan 29, 2025 | free cash flow | FY2025 | $450.00M | New |
| Jan 29, 2025 | effective tax rate | FY2025 | 24% | New |
| Jan 29, 2025 | interest and other debt expense | FY2025 | $185.00M | New |
| Oct 30, 2024 | Capital expenditures | FY2024 | $255.00M | Raised |
| Oct 30, 2024 | adjusted net income per diluted share | Q4 FY2024 | $0.78 – $0.88 | New |
| Oct 30, 2024 | adjusted net income per diluted share | FY2024 | $3.55 – $3.65 | Lowered |
| Oct 30, 2024 | free cash flow | FY2024 | $375.00M | Reaffirmed |
| Oct 30, 2024 | effective tax rate | FY2024 | 23% – 24% | Lowered |
| Oct 30, 2024 | interest and other debt expense | FY2024 | $170.00M | Raised |
| Jul 31, 2024 | Capital expenditures | FY2024 | $240.00M | Reaffirmed |
| Jul 31, 2024 | adjusted net income per diluted share | Q3 FY2024 | $1.20 – $1.30 | New |
| Jul 31, 2024 | adjusted net income per diluted share | FY2024 | $3.55 – $3.75 | Reaffirmed |
| Jul 31, 2024 | U.S. GAAP diluted EPS | Q3 FY2024 | $1.06 – $1.16 | New |
| Jul 31, 2024 | U.S. GAAP diluted EPS | FY2024 | $2.94 – $3.14 | New |
| Jul 31, 2024 | free cash flow | FY2024 | $375.00M | New |
| Jul 31, 2024 | effective tax rate | FY2024 | 24% – 25% | Reaffirmed |
| Jul 31, 2024 | interest and other debt expense | FY2024 | $165.00M | Lowered |
| May 2, 2024 | Capital expenditures | FY2024 | $240.00M | Reaffirmed |
| May 2, 2024 | adjusted net income per diluted share | Q2 FY2024 | $0.82 – $0.92 | New |
| May 2, 2024 | adjusted net income per diluted share | FY2024 | $3.55 – $3.75 | Reaffirmed |
| May 2, 2024 | free cash flow | FY2024 | $375.00M | Reaffirmed |
| May 2, 2024 | effective tax rate | FY2024 | 24% – 25% | Reaffirmed |
| May 2, 2024 | interest and other debt expense | FY2024 | $170.00M | Reaffirmed |
| Jan 31, 2024 | Capital expenditures | FY2024 | $240.00M | New |
| Jan 31, 2024 | adjusted net income per diluted share | Q1 FY2024 | $0.60 – $0.70 | New |
| Jan 31, 2024 | adjusted net income per diluted share | FY2024 | $3.55 – $3.75 | New |
| Jan 31, 2024 | free cash flow | FY2024 | $375.00M | New |
| Jan 31, 2024 | effective tax rate | FY2024 | 24% – 25% | New |
| Jan 31, 2024 | interest and other debt expense | FY2024 | $170.00M | New |
| Oct 25, 2023 | Capital expenditures | FY2023 | $230.00M | Reaffirmed |
| Oct 25, 2023 | adjusted net income per diluted share | FY2023 | $3.30 – $3.40 | Lowered |
| Oct 25, 2023 | U.S. GAAP diluted EPS | Q4 FY2023 | $0.43 – $0.53 | New |
| Oct 25, 2023 | U.S. GAAP diluted EPS | FY2023 | $2.79 – $2.89 | New |
| Oct 25, 2023 | free cash flow | FY2023 | $340.00M | Lowered |
| Oct 25, 2023 | effective tax rate | FY2023 | 24% | Reaffirmed |
| Oct 25, 2023 | interest expense before loss on early extinguishment of debt | FY2023 | $175.00M | Raised |
| Jul 26, 2023 | Capital expenditures | FY2023 | $230.00M | Lowered |
| Jul 26, 2023 | adjusted net income per diluted share | Q3 FY2023 | $1.10 – $1.20 | New |
| Jul 26, 2023 | adjusted net income per diluted share | FY2023 | $3.40 – $3.60 | Lowered |
| Jul 26, 2023 | free cash flow | FY2023 | $375.00M | New |
| Jul 26, 2023 | effective tax rate | FY2023 | 24% | Lowered |
| Jul 26, 2023 | interest expense before loss on early extinguishment of debt | FY2023 | $170.00M | New |
| Apr 26, 2023 | Capital expenditures | FY2023 | $250.00M | Reaffirmed |
| Apr 26, 2023 | adjusted net income per diluted share | FY2023 | $3.95 – $4.15 | Reaffirmed |
| Apr 26, 2023 | free cash flow | FY2023 | $425.00M | Reaffirmed |
| Apr 26, 2023 | effective tax rate | FY2023 | 24% – 25% | Reaffirmed |
| Apr 26, 2023 | interest expense before loss on early extinguishment of debt | FY2023 | $155.00M | Reaffirmed |
| Jan 25, 2023 | Capital expenditures | FY2023 | $250.00M | New |
| Jan 25, 2023 | adjusted net income per diluted share | Q1 FY2023 | $0.75 – $0.85 | New |
| Jan 25, 2023 | adjusted net income per diluted share | FY2023 | $3.95 – $4.15 | New |
| Jan 25, 2023 | free cash flow | FY2023 | $425.00M | New |
| Jan 25, 2023 | interest expense before loss on early extinguishment of debt | FY2023 | $155.00M | New |
| Jan 25, 2023 | effective tax rate | FY2023 | 24% – 25% | New |
| Oct 26, 2022 | adjusted net income per diluted share | Q4 FY2022 | $0.76 – $0.86 | New |
| Oct 26, 2022 | adjusted net income per diluted share | FY2022 | $3.90 – $4.00 | Lowered |
| Oct 26, 2022 | free cash flow | FY2022 | $350.00M | New |
| Jul 27, 2022 | adjusted net income per diluted share | Q3 FY2022 | $1.15 – $1.30 | New |
| Jul 27, 2022 | adjusted net income per diluted share | FY2022 | $3.90 – $4.05 | Reaffirmed |
| Jul 27, 2022 | Net income per diluted share as estimated | Q3 FY2022 | $1.14 – $1.29 | New |
| Jul 27, 2022 | Net income per diluted share as estimated | FY2022 | $3.62 – $3.77 | New |
| Jul 27, 2022 | free cash flow | FY2022 | $350.00M | Reaffirmed |
| Apr 27, 2022 | adjusted net income per diluted share | Q2 FY2022 | $0.90 – $1.00 | New |
| Apr 27, 2022 | adjusted net income per diluted share | FY2022 | $3.90 – $4.05 | Raised |
| Jan 26, 2022 | adjusted net income per diluted share | Q1 FY2022 | $0.70 – $0.80 | New |
| Jan 26, 2022 | adjusted net income per diluted share | FY2022 | $3.80 – $4.00 | New |
| Jan 26, 2022 | free cash flow | FY2022 | $350.00M | New |
| Jan 26, 2022 | effective tax rate | FY2022 | 25% | New |
| Oct 27, 2021 | adjusted net income per diluted share | Q4 FY2021 | $0.69 – $0.79 | New |
| Oct 27, 2021 | adjusted net income per diluted share | FY2021 | $3.30 – $3.40 | New |
| Oct 27, 2021 | free cash flow | FY2021 | $450.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Silgan filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Results
- Update
- Update
- News
- Results
- News
- Results
- News
- Results
- News
- News
- Results
- News
- News
See a number that looks wrong?